The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumor than a short course of radiotherapy for patients with rectal cancer—a type of bowel cancer.
Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer retrieved 11 September 2024 from https://medicalxpress.com/news/2024-09-radiotherapy-short-rectal-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.4 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Met Office says how long 'autumnal' weather will last ahead of long weekendCooler temperatures, wind and rain will feature in the forecast over the coming days, but what will the long weekend look like?
Read more »
NIH study finds routine lab tests fall short in diagnosing long COVIDA National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition
Read more »
Largest study of its kind finds common lab tests aren't reliable for diagnosing long COVIDA new study found that most routine laboratory tests are not reliable for diagnosing long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
Read more »
Routine lab tests fail to identify reliable biomarkers for long COVID, study findsStudy found no reliable clinical biomarkers for diagnosing PASC (long COVID) from routine laboratory tests, despite minor differences in some measures between infected and non-infected individuals.
Read more »
Study finds no clinically useful biomarkers for long COVID in routine lab testsWhether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).
Read more »
Sick days: Assessing the economic costs of long COVIDA new Yale study finds that the effects of long COVID have caused many Americans to miss extensive work time, and that 14% of study participants reported not returning to work in the months after their infection.
Read more »